2009
DOI: 10.1002/ana.21787
|View full text |Cite
|
Sign up to set email alerts
|

Imaging the future of stroke: I. Ischemia

Abstract: Envisioning the future of stroke appears daunting considering the milestones already achieved in stroke imaging. A historical perspective on the developments in stroke care provides a striking narrative of how imaging has transformed diagnosis, therapy, and prognosis of cerebrovascular disorders. Multimodal imaging techniques such as CT and MRI, incorporating parenchymal depictions, illustration of the vasculature, and perfusion data, can provide a wealth of information regarding ischemic pathophysiology. Key … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
71
0
1

Year Published

2010
2010
2022
2022

Publication Types

Select...
5
3
1

Relationship

1
8

Authors

Journals

citations
Cited by 69 publications
(72 citation statements)
references
References 132 publications
(118 reference statements)
0
71
0
1
Order By: Relevance
“…Moreover, the observation of glutamine increase in patients with TIA can help determine which areas had a lack of perfusion. The advantage of MRS compared with routinely used imaging techniques 34 is its capacity to identify recent ischemic events and predict outcome in the first hours after reperfusion, at a time when none of the other techniques detect any abnormality ( Figure 6) and where diagnostic blood biomarkers are less precise. 35 In conclusion, the ability to identify ischemic damage and predict the outcome (neuronal loss or recovery) based on metabolite concentrations between 3 and 8 hours after ischemia opens exciting perspectives for stroke diagnosis and treatment.…”
Section: Berthet Et Al Predictive Biomarkers Of Transient Ischemiamentioning
confidence: 99%
“…Moreover, the observation of glutamine increase in patients with TIA can help determine which areas had a lack of perfusion. The advantage of MRS compared with routinely used imaging techniques 34 is its capacity to identify recent ischemic events and predict outcome in the first hours after reperfusion, at a time when none of the other techniques detect any abnormality ( Figure 6) and where diagnostic blood biomarkers are less precise. 35 In conclusion, the ability to identify ischemic damage and predict the outcome (neuronal loss or recovery) based on metabolite concentrations between 3 and 8 hours after ischemia opens exciting perspectives for stroke diagnosis and treatment.…”
Section: Berthet Et Al Predictive Biomarkers Of Transient Ischemiamentioning
confidence: 99%
“…8,11 Longstanding hemodynamic compromise which was frequently observed in intracranial atherosclerosis may elicit collateral development and preconditioning to adapt to recurrent ischemia. 12 Thus, it is conceivable that patients with intracranial atherosclerosis may be 'prepared' and 'preconditioned' for the risk of subsequent stroke.…”
Section: Pre-stroke Hemodynamic Status In Patients With Intracranial mentioning
confidence: 99%
“…В случае, если внутриартериальные вмешательства проводят в клиниках общего профиля или их выполня-ют хирурги с недостаточным опытом работы, риск раз-вития осложнений повышается. Кроме того, пациенты с выраженным несоответствием зон нарушения диффу-зии и перфузии, по результатам нейровизуализирующих исследований головного мозга, получают больше пользы от проведения вмешательства и являются лучшими кан-дидатами [8]. Учет этих факторов при отборе пациентов может повлиять на улучшение результатов.…”
Section: Disclosuresunclassified
“…Furthermore, patients with large mismatches between diffusion and perfusion on brain neuroimaging studies are more likely to benefit from the procedures and are better candidates. 8 The introduction of these variables in patient selection may improve results.…”
mentioning
confidence: 99%